Mount Sinai Adopts SOPHiA AI Platform for Cancer Genomic Testing
Mount Sinai will deploy SOPHiA GENETICS’ AI platform to improve genomic testing, reduce analysis time, and scale cancer diagnostics workflows.
AI Lifesciences
Latest AI Lifesciences news, analysis and insights from AIM Media House
Task-Specialized Models Deliver Where General AI Fails in Healthcare
As healthcare leaders chase bigger LLMs, revenue cycle teams are achieving 30% denial reduction by narrowing AI scope and adding rigorous governance layers.
Eli Lilly to Acquire CrossBridge Bio for Up to $300 Million
Eli Lilly will acquire CrossBridge Bio for up to $300 million as it expands its ADC pipeline alongside investments in AI-driven drug discovery.
Novo Nordisk Partners With OpenAI to Accelerate Drug Development
Novo Nordisk partners with OpenAI to apply AI across drug discovery, manufacturing, and operations, with full deployment planned by the end of 2026.
Telcor Acquires Sample Healthcare for AI Revenue Cycle Workflows
TELCOR adds Sample Healthcare’s AI platform to automate administrative workflows in revenue cycle operations with human oversight.
Cleveland Clinic Deploys Luminai AI To Automate Referral Workflows
Cleveland Clinic is using Luminai’s AI platform to process and route referrals, aiming to reduce administrative burden and improve workflow efficiency across its system.
Memorial Sloan Kettering Partners Lumonus To Advance AI Radiation Planning
AI-driven radiation planning at MSK moves toward wider clinical use through improving consistency and handling complex patient-specific constraints.
The AI Fix for Healthcare Billing Didn’t Come From Silicon Valley
A system reducing millions in denied claims was built in smaller Indian cities, reshaping how healthcare revenue workflows are executed.
Pfizer Built an AI Advantage in Drug Development Speed
Pfizer frees 16,000 researcher hours annually through AI deployment across discovery and manufacturing.
Hims & Hers Outlines Plan to Embed AI Across Care Delivery Workflows
Hims & Hers said it is integrating AI across intake, triage, and follow-up, positioning it as core infrastructure for care delivery.
10 Healthcare Leaders Turning AI into Measurable Outcomes
Some reduced documentation. Some accelerated diagnosis. Others freed capacity. All measured impact and prioritized clinician experience.
BD Expands AI-Enabled Medication Dispensing System to Europe
BD expands its Pyxis dispensing system and Incada analytics platform to Europe, adding AI-driven inventory visibility and workflow automation for hospitals.
University of Toledo Health Expands Nabla AI Setup After Measurable Gains
University of Toledo Health expands Nabla’s ambient AI after a pilot shows faster chart closure, reduced backlog, and improved revenue cycle performance.
Eli Lilly Expands Insilico AI Drug Discovery Deal to $2.75 Billion
Eli Lilly extended its Insilico deal to $2.75 billion, advancing AI-driven drug discovery and development programs.
Christ Hospital Tests AI App for Rapid Heart Attack Detection
“Queen of Hearts” analyzes EKGs in seconds to support faster treatment decisions.
Molecular Data Is Now Picking Pancreatic Cancer's First Drug
Half of pancreatic cancer patients may be getting harsher chemotherapy than they need. AI is identifying which half.
Verily Spins out of Alphabet's Other Bets Portfolio as Verily Health Inc.
Verily secures $300 million as Alphabet steps back to minority investor
GE HealthCare, Springbok Analytics to Use AI-Powered MRI for Muscle Analysis
The deal extends Springbok's AI muscle-mapping platform, used by over 80 pro sports teams, into advanced MRI environments.
AI Walked Into a Hospital. It Became an Accountant
85% of healthcare executives say AI is boosting revenue. The gains are coming from billing, not breakthroughs
Mount Sinai Health Applies AI to Uncover Hidden Costs in Supply Chain
Midstream system scans contracts and payments to surface savings opportunities